Improved inference for vaccine-induced immune responses via shape-constrained methods.

62G05 62G07 62G10 62P10 Hellinger distance logconcave shape-constraint test of stochastic dominance unimodal vaccine trial

Journal

Electronic journal of statistics
ISSN: 1935-7524
Titre abrégé: Electron J Stat
Pays: United States
ID NLM: 101480209

Informations de publication

Date de publication:
2022
Historique:
medline: 1 1 2022
pubmed: 1 1 2022
entrez: 17 11 2023
Statut: ppublish

Résumé

We study the performance of shape-constrained methods for evaluating immune response profiles from early-phase vaccine trials. The motivating problem for this work involves quantifying and comparing the IgG binding immune responses to the first and second variable loops (V1V2 region) arising in HVTN 097 and HVTN 100 HIV vaccine trials. We consider unimodal and log-concave shape-constrained methods to compare the immune profiles of the two vaccines, which is reasonable because the data support that the underlying densities of the immune responses could have these shapes. To this end, we develop novel shape-constrained tests of stochastic dominance and shape-constrained plug-in estimators of the squared Hellinger distance between two densities. Our techniques are either tuning parameter free, or rely on only one tuning parameter, but their performance is either better (the tests of stochastic dominance) or comparable with the nonparametric methods (the estimators of the squared Hellinger distance). The minimal dependence on tuning parameters is especially desirable in clinical contexts where analyses must be prespecified and reproducible. Our methods are supported by theoretical results and simulation studies.

Identifiants

pubmed: 37974631
doi: 10.1214/22-ejs2079
pmc: PMC10653201
mid: NIHMS1923278
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5852-5933

Subventions

Organisme : NLM NIH HHS
ID : DP2 LM013340
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068635
Pays : United States

Références

N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Health Care Manag Sci. 2004 Aug;7(3):207-15
pubmed: 15648563
Ann Stat. 2009 Jun 1;37(3):1299-1331
pubmed: 19881896
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
Sci Transl Med. 2019 Sep 18;11(510):
pubmed: 31534016
Lancet HIV. 2018 Jul;5(7):e366-e378
pubmed: 29898870
BMJ Open. 2014 Oct 21;4(10):e005249
pubmed: 25335959
Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S68-80
pubmed: 9566468
Metrika. 2009 Mar;69(2-3):227-247
pubmed: 23087487
Ann Stat. 2016;44(3):954-981
pubmed: 28966409

Auteurs

Nilanjana Laha (N)

Department of Biostatistics, Harvard University, 677 Huntington Ave, Boston, MA 02115, U.S.A.

Zoe Moodie (Z)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.

Ying Huang (Y)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.

Alex Luedtke (A)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Department of Biostatistics, University of Washington, Seattle, WA 98195.

Classifications MeSH